These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 35484726)
1. Harnessing Natural Products by a Pharmacophore-Oriented Semisynthesis Approach for the Discovery of Potential Anti-SARS-CoV-2 Agents. Zhou YF; Yan BC; Yang Q; Long XY; Zhang DQ; Luo RH; Wang HY; Sun HD; Xue XS; Zheng YT; Puno PT Angew Chem Int Ed Engl; 2022 Jul; 61(28):e202201684. PubMed ID: 35484726 [TBL] [Abstract][Full Text] [Related]
2. A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein. Littler DR; Liu M; McAuley JL; Lowery SA; Illing PT; Gully BS; Purcell AW; Chandrashekaran IR; Perlman S; Purcell DFJ; Quinn RJ; Rossjohn J J Biol Chem; 2021 Dec; 297(6):101362. PubMed ID: 34756886 [TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Natural Products with Antiviral Activities. Sun ZG; Li ZN; Miao XW; Li S; Zhu HL Mini Rev Med Chem; 2021; 21(14):1888-1908. PubMed ID: 33663367 [TBL] [Abstract][Full Text] [Related]
4. Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review. Frediansyah A; Sofyantoro F; Alhumaid S; Al Mutair A; Albayat H; Altaweil HI; Al-Afghani HM; AlRamadhan AA; AlGhazal MR; Turkistani SA; Abuzaid AA; Rabaan AA Molecules; 2022 Jul; 27(13):. PubMed ID: 35807550 [TBL] [Abstract][Full Text] [Related]
5. Target-Specific Drug Discovery of Natural Products against SARS-CoV-2 Life Cycle and Cytokine Storm in COVID-19. Lee M; Park J; Cho IH Am J Chin Med; 2022; 50(4):927-959. PubMed ID: 35729089 [TBL] [Abstract][Full Text] [Related]
6. Natural Products with Tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 Effects: A Drug Discovery Perspective against SARS-CoV-2. da Cunha LNOL; Tizziani T; Souza GB; Moreira MA; Neto JSS; Dos Santos CVD; de Carvalho MG; Dalmarco EM; Turqueti LB; Scotti MT; Scotti L; de Assis FF; Braga AL; Sandjo LP Curr Med Chem; 2022; 29(14):2530-2564. PubMed ID: 34313197 [TBL] [Abstract][Full Text] [Related]
7. Promising natural products against SARS-CoV-2: Structure, function, and clinical trials. Zhao Y; Deng S; Bai Y; Guo J; Kai G; Huang X; Jia X Phytother Res; 2022 Oct; 36(10):3833-3858. PubMed ID: 35932157 [TBL] [Abstract][Full Text] [Related]
9. Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation. Hu LC; Ding CH; Li HY; Li ZZ; Chen Y; Li LP; Li WZ; Liu WS J Food Biochem; 2022 May; 46(5):e14085. PubMed ID: 35128681 [TBL] [Abstract][Full Text] [Related]
10. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro. Hahn F; Wangen C; Häge S; Peter AS; Dobler G; Hurst B; Julander J; Fuchs J; Ruzsics Z; Überla K; Jäck HM; Ptak R; Muehler A; Gröppel M; Vitt D; Peelen E; Kohlhof H; Marschall M Viruses; 2020 Dec; 12(12):. PubMed ID: 33291455 [TBL] [Abstract][Full Text] [Related]
11. Uncovering Flexible Active Site Conformations of SARS-CoV-2 3CL Proteases through Protease Pharmacophore Clusters and COVID-19 Drug Repurposing. Pathak N; Chen YT; Hsu YC; Hsu NY; Kuo CJ; Tsai HP; Kang JJ; Huang CH; Chang SY; Chang YH; Liang PH; Yang JM ACS Nano; 2021 Jan; 15(1):857-872. PubMed ID: 33373194 [TBL] [Abstract][Full Text] [Related]
12. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease. Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462 [TBL] [Abstract][Full Text] [Related]
13. Antiviral plant-derived natural products to combat RNA viruses: Targets throughout the viral life cycle. Owen L; Laird K; Shivkumar M Lett Appl Microbiol; 2022 Sep; 75(3):476-499. PubMed ID: 34953146 [TBL] [Abstract][Full Text] [Related]
14. Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism. Shawon J; Akter Z; Hossen MM; Akter Y; Sayeed A; Junaid M; Afrose SS; Khan MA Curr Pharm Des; 2020; 26(41):5241-5260. PubMed ID: 33155902 [TBL] [Abstract][Full Text] [Related]
15. In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease. Cheng AJT; Macalino SJY; Billones JB; Balolong MP; Murao LAE; Carrillo MCO J Mol Model; 2022 Oct; 28(11):345. PubMed ID: 36205801 [TBL] [Abstract][Full Text] [Related]